Developer docs
API playgroundTry for free, no card

Search company profiles

myLaurel

Full company profile

uuid0000dov

Namestring
myLaurel
Legal namestring
Nobis, LLC d/b/a myLaurel
Company typeenum
Private
Founded yearint
2016
Descriptiontext

myLaurel (legal entity Nobis, LLC d/b/a myLaurel) is a New York–based, venture-backed healthcare services company founded in 2016 that delivers hospital-level acute and transitional care in patients' homes. The company operates three integrated service lines — Acute Care at Home, Rapid Advanced Care (90-minute response for high-acuity symptoms), and Recovery at Home (14–30 day post-discharge transitional care) — combining field responders, in-home point-of-care diagnostics (blood tests, 12-lead EKG, ultrasound, viral screenings), telehealth providers, and a proprietary care coordination platform called CareDash. Underlying operations are supported by AI-powered logistics designed to dispatch clinical teams to a patient's home within 90 minutes of referral.

myLaurel sells exclusively to enterprise customers — U.S. health systems, health plans (including Medicare Advantage and risk-bearing entities), and PACE programs — and does not operate a direct-to-consumer channel. The business model is 100% at-risk: fees are contingent on successful patient outcomes, and if a patient requires hospitalization or an ED visit during the risk window, myLaurel is not paid. Contracts are multi-year and structured around reducing 30-day readmissions, ED diversion, length of stay, and overall cost of care for high-complexity, frail, and elderly populations.

The go-to-market is enterprise field sales targeting health system CFOs, CEOs, and clinical leaders, as well as health plan decision-makers. Named anchor partners include Ochsner Health, Maimonides Health, and University Medical Center New Orleans, with participation in thought leadership alongside Jefferson Health, Tampa General Hospital, and Providence Health. Reported outcomes include a 49% reduction in 30-day readmissions (versus a matched control), 91% of patients bypassing hospitalization, a 97 NPS, and a minimum 3:1 ROI for partners within the first 90 days. The company is HIPAA-compliant, operates exclusively in the United States, and has raised disclosed equity exceeding $118M since inception from investors including Deerfield Management, Google Ventures, SteelSky Ventures, City Light Capital, Frist Cressey Ventures, Town Hall Ventures, Acumen, and Emerson Collective.

Short descriptiontext

myLaurel delivers hospital-level acute and transitional care in patients' homes under 100% at-risk contracts with U.S. health systems and health plans, serving high-complexity and elderly populations to reduce hospitalizations, readmissions, and bed capacity strain.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
acute home care, transitional care services, hospital at home, in-home clinical care, readmission reduction
Industry4 codes
PRIMARYHLALABAC
Hospital-at-Home & Acute Virtual Care Platforms
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
SECONDARYHLALABAG
Post-Acute & Transitional Care Virtual Platforms (SNF/home health coordination)
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
SECONDARYHLALAFAH
Hospital-at-Home & Acute-at-Home Remote Monitoring (step-down, escalation workflows)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHSABAHAF
Post-Acute & Transitional 24/7 In-Home Care (Hospital/SNF Discharge)
NAICS code2 codes
  • Home Health Care Services62161
  • Ambulatory Health Care Services621
SIC code2 codes
  • Services-Home Health Care Services8082
  • Services-Health Services8000
Product category
Acute Home Healthcare Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1At-Risk Contracts with Health Systems
TypeUsage Based
Description

Health systems pay for acute care at home services under at-risk arrangements where myLaurel's fees are contingent on successful patient outcomes. If patients require hospitalization during the care period, the health system does not pay myLaurel's fees.

mylaurelhealth.com
2At-Risk Contracts with Health Plans
TypeUsage Based
Description

Health plans pay under at-risk arrangements where myLaurel goes at risk for outcomes. Services generate cost savings by reducing unnecessary ED visits, observation stays, and inpatient admissions. If patients have an ED or inpatient admission within the risk period, myLaurel does not get paid.

mylaurelhealth.com
3PACE Program Partnerships
TypeUsage Based
Description

Partnerships with Program of All-Inclusive Care for the Elderly (PACE) organizations providing in-home acute care for high-complexity elderly patients under at-risk arrangements.

mylaurelhealth.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Outcome-based / At-risk pricing model
ModelOutcome Based/ PerformanceBilling cadenceMulti-year contract
Notes

No specific pricing disclosed publicly. myLaurel is 100% aligned with partners—fees are at risk if patients require hospitalization during the care period. Demonstrated ROI of minimum 3:1 for partners.

mylaurelhealth.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

myLaurel delivers hospital-level acute and transitional care in patients' homes through a hybrid model that combines hands-on clinical visits with telehealth and AI-powered logistics. The company operates three service lines—Acute Care at Home, Rapid Advanced Care (90-minute response), and Recovery at Home (14–30 day post-discharge)—selling exclusively to health systems, health plans, and PACE programs under 100% at-risk, outcome-based contracts.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • 49% reduction in 30-day readmissions
+7 more records
Product overview1 text field

myLaurel is a hybrid care-at-home platform offering three integrated service lines: Acute Care at Home™ provides hospital-level acute care in the patient's home; Rapid Advanced Care™ delivers 90-minute response for acute symptoms to prevent ED visits; and Recovery at Home™ offers 14-30 day post-discharge transitional care to reduce readmissions. All services use a blended model combining in-person clinical visits with telehealth and telephonic follow-up, supported by proprietary care management technology.

Product and service3 records
1Acute Care at Home
CategoryAcute home healthcare services
Description

Hospital-level acute and transitional care delivered in the patient's home, combining hands-on clinical care with virtual technology. Targeted at health systems and payers serving high-complexity patients to prevent unnecessary hospitalizations, free bed space, and reduce costs.

2Rapid Advanced Care
CategoryAcute home healthcare services
Description

Pre-hospital acute care service providing on-demand treatment for high-acuity symptoms in the patient's home within 90 minutes of referral. Reduces preventable ED and inpatient utilization for health plan and health system partners.

3Recovery at Home
CategoryTransitional care services
Description

Post-discharge transitional care program spanning 14-30 days that minimizes avoidable readmissions through personalized support, medication reconciliation, and continuous care coordination following hospitalization.

Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Major health system partner operating 46 hospitals and 370+ health and urgent care centers in the Gulf South. myLaurel's Acute Care at Home program is deployed in Ochsner's ED, observation, and inpatient units to reduce readmissions and improve capacity management. Case study customer with published outcomes data.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Brooklyn-based health system partner implementing myLaurel's hospital-at-home care model. CMO Dr. John Marshall has publicly endorsed the partnership anticipating improved patient recovery outcomes.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

New Orleans hospital implementing myLaurel's care-at-home services as part of commitment to improving patient experience and enabling recovery at home.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Executive panel webinar participant with myLaurel discussing how health systems are unlocking capacity and driving financial performance with care-at-home models.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Executive panel webinar participant with myLaurel discussing scaling acute care at home as an operational standard for hospital capacity management.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Executive panel participant in white paper discussion on capacity constraints and scaling acute care at home. Senior clinical executives contributed to myLaurel's thought leadership.

Strategic tierSupportingTypeTechnology or Integration
Description

Independent consultant partner that collected and validated data for myLaurel's PACE program case study (494 patients, April 2022 - November 2023) demonstrating 6:1 ROI and clinical outcomes.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Amedisys is one of the largest U.S. home health and hospice providers, with growing hospital-at-home capabilities via its Contessa acquisition. It overlaps with myLaurel on post-acute and home-based skilled care delivery.

TypeBroad incumbent
Description

LHC Group is a large national home health and post-acute provider (now part of UnitedHealth Group/Optum). It is broadly comparable to myLaurel on home health and transitional care delivery, though it operates at much larger scale and via traditional fee-for-service contracts.

TypeEmerging player
Description

Vivify Health provides remote patient monitoring and virtual care platforms used by health plans and providers to manage chronic and post-acute populations at home. It is comparable to myLaurel on the post-discharge and chronic-condition management use case.

TypeEmerging player
Description

Current Health, owned by Best Buy Health, offers a remote patient monitoring and care-at-home platform used by health systems for acute and post-acute care. It competes with myLaurel on the technology layer supporting in-home acute care delivery.

5Heal (Humana)
TypeRegional player
Description

Heal, now part of Humana, provides in-home primary, urgent, and post-acute care, originally focused on specific U.S. markets. It is comparable to myLaurel on in-home care delivery for complex and post-discharge patients, though with a different geographic footprint.

6Biofourmis
TypeEmerging player
Description

Biofourmis provides AI-driven remote monitoring and hospital-at-home capabilities, with FDA-cleared analytics for acute care. It overlaps with myLaurel on the technology-enabled acute-at-home and post-discharge monitoring use cases.

TypeDirect peer
Description

DispatchHealth delivers hospital-level acute care in the home, including ED avoidance and post-discharge transitional care, with health system and payer partnerships. It is the most direct competitor to myLaurel's Acute Care at Home and Rapid Advanced Care lines.

TypeDirect peer
Description

Medically Home operates a hospital-at-home platform enabling health systems to deliver acute and post-acute care in the home, with a virtual command center and in-home clinician network that directly overlaps myLaurel's care model.

TypeDirect peer
Description

Contessa Health pioneered hospital-at-home and skilled nursing facility-at-home programs for health systems and payers, and is now part of Amedisys. It competes head-to-head with myLaurel on acute and transitional care-at-home contracts.

10CenterWell Home Health (Humana)
TypeBroad incumbent
Description

Humana's CenterWell is a large home health and primary care provider serving Medicare Advantage populations, including complex and post-acute patients. It is a broader incumbent with overlapping capabilities in home-based acute and transitional care.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds9 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors16 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

myLaurel

Acute Home Healthcare Servicesmylaurelhealth.com

myLaurel delivers hospital-level acute and transitional care in patients' homes under 100% at-risk contracts with U.S. health systems and health plans, serving high-complexity and elderly populations to reduce hospitalizations, readmissions, and bed capacity strain.

What myLaurel does

myLaurel (legal entity Nobis, LLC d/b/a myLaurel) is a New York–based, venture-backed healthcare services company founded in 2016 that delivers hospital-level acute and transitional care in patients' homes. The company operates three integrated service lines — Acute Care at Home, Rapid Advanced Care (90-minute response for high-acuity symptoms), and Recovery at Home (14–30 day post-discharge transitional care) — combining field responders, in-home point-of-care diagnostics (blood tests, 12-lead EKG, ultrasound, viral screenings), telehealth providers, and a proprietary care coordination platform called CareDash. Underlying operations are supported by AI-powered logistics designed to dispatch clinical teams to a patient's home within 90 minutes of referral.

myLaurel sells exclusively to enterprise customers — U.S. health systems, health plans (including Medicare Advantage and risk-bearing entities), and PACE programs — and does not operate a direct-to-consumer channel. The business model is 100% at-risk: fees are contingent on successful patient outcomes, and if a patient requires hospitalization or an ED visit during the risk window, myLaurel is not paid. Contracts are multi-year and structured around reducing 30-day readmissions, ED diversion, length of stay, and overall cost of care for high-complexity, frail, and elderly populations.

The go-to-market is enterprise field sales targeting health system CFOs, CEOs, and clinical leaders, as well as health plan decision-makers. Named anchor partners include Ochsner Health, Maimonides Health, and University Medical Center New Orleans, with participation in thought leadership alongside Jefferson Health, Tampa General Hospital, and Providence Health. Reported outcomes include a 49% reduction in 30-day readmissions (versus a matched control), 91% of patients bypassing hospitalization, a 97 NPS, and a minimum 3:1 ROI for partners within the first 90 days. The company is HIPAA-compliant, operates exclusively in the United States, and has raised disclosed equity exceeding $118M since inception from investors including Deerfield Management, Google Ventures, SteelSky Ventures, City Light Capital, Frist Cressey Ventures, Town Hall Ventures, Acumen, and Emerson Collective.

myLaurel firmographics

Firmographics
Name
myLaurel
Legal name
Nobis, LLC d/b/a myLaurel
Website
https://mylaurelhealth.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
51–100 employees
Short description
myLaurel delivers hospital-level acute and transitional care in patients' homes under 100% at-risk contracts with U.S. health systems and health plans, serving high-complexity and elderly populations to reduce hospitalizations, readmissions, and bed capacity strain.
Ownership category
akta.pro rank

myLaurel industry classification

Industry
Product category
Acute Home Healthcare Services
NAICS
Home Health Care Services (62161), Ambulatory Health Care Services (621)
SIC
Services-Home Health Care Services (8082), Services-Health Services (8000)
akta.pro industry
PRIMARYHLALABAC
Hospital-at-Home & Acute Virtual Care Platforms
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
SECONDARYHLALABAG
Post-Acute & Transitional Care Virtual Platforms (SNF/home health coordination)
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
SECONDARYHLALAFAH
Hospital-at-Home & Acute-at-Home Remote Monitoring (step-down, escalation workflows)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHSABAHAF
Post-Acute & Transitional 24/7 In-Home Care (Hospital/SNF Discharge)

Keywords

  • Acute home care
  • Transitional care services
  • Hospital at home
  • In-home clinical care
  • Readmission reduction

Where myLaurel is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

myLaurel business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. At-Risk Contracts with Health Systems: Health systems pay for acute care at home services under at-risk arrangements where myLaurel's fees are contingent on successful patient outcomes. If patients require hospitalization during the care period, the health system does not pay myLaurel's fees.
  2. At-Risk Contracts with Health Plans: Health plans pay under at-risk arrangements where myLaurel goes at risk for outcomes. Services generate cost savings by reducing unnecessary ED visits, observation stays, and inpatient admissions. If patients have an ED or inpatient admission within the risk period, myLaurel does not get paid.
  3. PACE Program Partnerships: Partnerships with Program of All-Inclusive Care for the Elderly (PACE) organizations providing in-home acute care for high-complexity elderly patients under at-risk arrangements.

Pricing tiers

ModelBillingPrice
Outcome Based/ PerformanceMulti-year contractOutcome-based / At-risk pricing model

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

myLaurel product offering

Product offering

Core offering

myLaurel delivers hospital-level acute and transitional care in patients' homes through a hybrid model that combines hands-on clinical visits with telehealth and AI-powered logistics. The company operates three service lines—Acute Care at Home, Rapid Advanced Care (90-minute response), and Recovery at Home (14–30 day post-discharge)—selling exclusively to health systems, health plans, and PACE programs under 100% at-risk, outcome-based contracts.

Product overview

myLaurel is a hybrid care-at-home platform offering three integrated service lines: Acute Care at Home™ provides hospital-level acute care in the patient's home; Rapid Advanced Care™ delivers 90-minute response for acute symptoms to prevent ED visits; and Recovery at Home™ offers 14-30 day post-discharge transitional care to reduce readmissions. All services use a blended model combining in-person clinical visits with telehealth and telephonic follow-up, supported by proprietary care management technology.

Differentiator

Problem solved

Functional benefit

Products and services

  • Acute Care at Home Hospital-level acute and transitional care delivered in the patient's home, combining hands-on clinical care with virtual technology. Targeted at health systems and payers serving high-complexity patients to prevent unnecessary hospitalizations, free bed space, and reduce costs.
  • Rapid Advanced Care Pre-hospital acute care service providing on-demand treatment for high-acuity symptoms in the patient's home within 90 minutes of referral. Reduces preventable ED and inpatient utilization for health plan and health system partners.
  • Recovery at Home Post-discharge transitional care program spanning 14-30 days that minimizes avoidable readmissions through personalized support, medication reconciliation, and continuous care coordination following hospitalization.

Quantifiable outcome

  • 49% reduction in 30-day readmissions
  • +7 more outcomes

Companies that use myLaurel

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

myLaurel technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

myLaurel partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered flagship, core and supporting.

  • Ochsner HealthflagshipStrategic or Co-development PartnerMajor health system partner operating 46 hospitals and 370+ health and urgent care centers in the Gulf South. myLaurel's Acute Care at Home program is deployed in Ochsner's ED, observation, and inpatient units to reduce readmissions and improve capacity management. Case study customer with published outcomes data.
  • Maimonides HealthcoreStrategic or Co-development PartnerBrooklyn-based health system partner implementing myLaurel's hospital-at-home care model. CMO Dr. John Marshall has publicly endorsed the partnership anticipating improved patient recovery outcomes.
  • University Medical Center New OrleanscoreStrategic or Co-development PartnerNew Orleans hospital implementing myLaurel's care-at-home services as part of commitment to improving patient experience and enabling recovery at home.
  • Jefferson HealthcoreStrategic or Co-development PartnerExecutive panel webinar participant with myLaurel discussing how health systems are unlocking capacity and driving financial performance with care-at-home models.
  • Tampa General HospitalcoreStrategic or Co-development PartnerExecutive panel webinar participant with myLaurel discussing scaling acute care at home as an operational standard for hospital capacity management.
  • Providence HealthcoreStrategic or Co-development PartnerExecutive panel participant in white paper discussion on capacity constraints and scaling acute care at home. Senior clinical executives contributed to myLaurel's thought leadership.
  • Humbi AIsupportingTechnology or IntegrationIndependent consultant partner that collected and validated data for myLaurel's PACE program case study (494 patients, April 2022 - November 2023) demonstrating 6:1 ROI and clinical outcomes.

Scale indicators13 records

Recent moves6 records

Expansion highlights6 records

myLaurel competitors and assessment

Company assessment

Broad incumbents

  • Amedisys: Amedisys is one of the largest U.S. home health and hospice providers, with growing hospital-at-home capabilities via its Contessa acquisition. It overlaps with myLaurel on post-acute and home-based skilled care delivery.
  • LHC Group: LHC Group is a large national home health and post-acute provider (now part of UnitedHealth Group/Optum). It is broadly comparable to myLaurel on home health and transitional care delivery, though it operates at much larger scale and via traditional fee-for-service contracts.
  • CenterWell Home Health (Humana): Humana's CenterWell is a large home health and primary care provider serving Medicare Advantage populations, including complex and post-acute patients. It is a broader incumbent with overlapping capabilities in home-based acute and transitional care.

Emerging players

  • Vivify Health: Vivify Health provides remote patient monitoring and virtual care platforms used by health plans and providers to manage chronic and post-acute populations at home. It is comparable to myLaurel on the post-discharge and chronic-condition management use case.
  • Current Health (Best Buy Health): Current Health, owned by Best Buy Health, offers a remote patient monitoring and care-at-home platform used by health systems for acute and post-acute care. It competes with myLaurel on the technology layer supporting in-home acute care delivery.
  • Biofourmis: Biofourmis provides AI-driven remote monitoring and hospital-at-home capabilities, with FDA-cleared analytics for acute care. It overlaps with myLaurel on the technology-enabled acute-at-home and post-discharge monitoring use cases.

Regional players

  • Heal (Humana): Heal, now part of Humana, provides in-home primary, urgent, and post-acute care, originally focused on specific U.S. markets. It is comparable to myLaurel on in-home care delivery for complex and post-discharge patients, though with a different geographic footprint.

Direct peers

  • DispatchHealth: DispatchHealth delivers hospital-level acute care in the home, including ED avoidance and post-discharge transitional care, with health system and payer partnerships. It is the most direct competitor to myLaurel's Acute Care at Home and Rapid Advanced Care lines.
  • Medically Home: Medically Home operates a hospital-at-home platform enabling health systems to deliver acute and post-acute care in the home, with a virtual command center and in-home clinician network that directly overlaps myLaurel's care model.
  • Contessa Health (Amedisys): Contessa Health pioneered hospital-at-home and skilled nursing facility-at-home programs for health systems and payers, and is now part of Amedisys. It competes head-to-head with myLaurel on acute and transitional care-at-home contracts.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

myLaurel social profiles

Digital presence

myLaurel compliance and trust

Trust signal

Compliance1 record

myLaurel financial estimates

Financial estimate

Revenue estimate

Valuation estimate

myLaurel leadership team

Management profile

Number of profiles

Profiles11 records

myLaurel funding detail

Funding detail

Funding overview

Funding rounds9 records

Investors16 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

myLaurel M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about myLaurel

What does myLaurel do?

myLaurel delivers hospital-level acute and transitional care in patients' homes through a hybrid model that combines hands-on clinical visits with telehealth and AI-powered logistics. The company operates three service lines—Acute Care at Home, Rapid Advanced Care (90-minute response), and Recovery at Home (14–30 day post-discharge)—selling exclusively to health systems, health plans, and PACE programs under 100% at-risk, outcome-based contracts.

Is myLaurel a public or private company?

myLaurel is a private company. It is classified as venture growth investor backed and is currently operating.

When was myLaurel founded?

myLaurel was founded in 2016. It employs 51 to 100 people.

Where is myLaurel based?

myLaurel is headquartered in New York, United States, in the North America region.

How does myLaurel make money?

Three revenue lines are on record. At-Risk Contracts with Health Systems are the primary driver. The others are at-Risk Contracts with Health Plans and PACE Program Partnerships.

Who are myLaurel's main competitors?

Broad incumbents on record are Amedisys, LHC Group and CenterWell Home Health (Humana). Emerging players are Vivify Health, Current Health (Best Buy Health) and Biofourmis. Heal (Humana) is listed as a regional player. Direct peers are DispatchHealth, Medically Home and Contessa Health (Amedisys).

Does myLaurel have an API?

No public API is recorded for myLaurel.

What industry is myLaurel in?

myLaurel's product category is Acute Home Healthcare Services. Its primary akta.pro industry code is HLALABAC, Hospital-at-Home & Acute Virtual Care Platforms, with a secondary code of HLALABAG, Post-Acute & Transitional Care Virtual Platforms (SNF/home health coordination). Its NAICS code is 62161 and its SIC code is 8082.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BeckershospitalreviewNew York City system cuts readmissions with acute care at home programMaimonides Health partnered with myLaurel in May 2025 to provide acute care at home for frail, medically complex patients. The program served over 1,200 patients, cutting 30-day readmissions by 43% and saving 2.29 hospital bed days per patient. The system plans to expand the program to additional care sites and specialty service lines.PR NewswiremyLaurel Reports Breakout 2025 Growth: 400% Partner Increase and 575% Surge in Patients Served, Drives Health-at-Home MomentummyLaurel, a tech-enabled mobile medical group, reported record-breaking 2025 growth with a 400% increase in health system partners, 5x growth in facilities served, and a 575% surge in patients served across key markets including Philadelphia, Houston, New York City, and New Orleans. The company also completed capital raises led by Deerfield Management, GV (Google Ventures), and newly welcomed SteelSky Ventures. Clinical outcomes include a 33% lower Emergency Department utilization rate, a 49% absolute reduction in readmissions, and 8 bed days saved daily, while the company's Net Promoter Score improved from 93 to 97.HomepageMoney Moves: MonCap Invests $20M in FERT; Borski Leads £1.4M Round in Rem3dy Health; SteelSky Ventures Backs myLaurelMonCap invested $20 million in FERT, a fertility clinic EMR, while Rem3dy Health raised £1.4 million led by Borski Fund, and SteelSky Ventures backed myLaurel's hospital-at-home platform. FERT joins MonCap's fertility ecosystem serving 70% of North American fertility patients, and myLaurel reports a 49% reduction in hospital readmissions.FinSMEsmyLaurel Receives Investment From SteelSky VenturesmyLaurel, an Atlanta-based in-home care company, received an undisclosed investment from SteelSky Ventures. The funds will support its national expansion of a hospital-aligned, in-home acute care model across major U.S. health systems. The company aims to expand capacity, reduce costs, and improve patient experiences.PR NewswireSteelSky Ventures Leads Investment in myLaurel to Redefine Acute and Transitional Care at HomeSteelSky Ventures led the latest investment round in myLaurel, joining previous investors Deerfield Management and Google Ventures to support the national expansion of myLaurel's hospital-aligned, in-home acute care model across major U.S. health systems. The company operates in New York City and New Orleans, partnering with health systems including Ochsner Health, LCMC Health, and Maimonides Medical Center, and reports a 49 percent reduction in readmissions and a 6-to-1 return on investment for hospital partners. Maria Toler, founding and managing partner at SteelSky Ventures, will join myLaurel's Board of Directors as part of the deal.LinkedInWe are delighted to announce that SteelSky Ventures has led the latest investment round in myLaurel®, joining existing investors Deerfield Management and Google Ventures (GV)! This funding will…SteelSky Ventures led a funding round in health tech startup myLaurel with an investment of an undisclosed amount, joining Deerfield Management and Google Ventures. The funding aims to support medical research and patient care in San Diego.MylaurelhealthSteelSky Ventures Leads Investment in myLaurel to Redefine Acute and Transitional Care at Home — myLaurelSteelSky Ventures led a funding round for myLaurel, a healthcare technology company specializing in hospital-level in-home care, to support its expansion across the U.S. The company's care model aims to reduce hospital readmissions and improve outcomes, partnering with major health systems and leveraging AI technology.BenzingaSteelSky Ventures Leads Investment in myLaurel to Redefine Acute and Transitional Care at HomeSteelSky Ventures has led an investment round in myLaurel, joining previous investors Deerfield Management and Google Ventures, to fund myLaurel's national expansion of its hospital-aligned, in-home acute care model. The company reports a 49 percent reduction in readmissions, a 6-to-1 return on investment for hospital partners, and patient satisfaction scores above 90 NPS, demonstrating both clinical outcomes and financial value. myLaurel currently operates in New York City and New Orleans, partnering with health systems including Ochsner Health, LCMC Health, and Maimonides Medical Center.